title: Continuous hemofiltration dose calculation in a newborn patient with congenital heart disease and preoperative renal failure.
abstract: OBJECTIVE
  To report a case of a newborn patient with renal failure due to polycystic kidneys requiring renal replacement therapy, and total anomalous pulmonary venous return requiring major cardiosurgical intervention.
  
  
  METHODS
  Pediatric cardiosurgery operatory room and pediatric cardiologic intensive care.
  
  
  METHODS
  A 6-day-old newborn child weighing 3.1 kg.
  
  
  RESULTS
  Renal function (creatinine value and urine output) was monitored during the course of the operation and intraoperative renal replacement therapy was not initiated. Serum creatinine concentration decreased from 4.4 to 3 mg/dL at cardiopulmonary bypass (CPB) start and to 1.5 at the end of surgery: the creatinine decrease was provided by the dilutional effect of CPB priming and the infusion of fresh blood from transfusions together with an adequate filtration rate (800 m/L in about 120 minutes). After the operation, extracorporeal membrane oxygenation (ECMO) for ventricular dysfunction and continuous hemofiltration for anuria refractory to medical therapy were prescribed. The hemofiltration machine was set in parallel with the ECMO machine at a blood flow rate of 60 ml/min and a predilution replacement solution infusion of 600 ml/h (4.5 ml/min of creatinine clearance once adjusted on extracorporeal circuits; 3000 mL/m2 hemofiltration): after a single hemofiltration session lasting 96 hours, serum creatinine reached optimal steady state levels around 0.5 mg/dL on postoperative day 2 and 3.
  
  
  CONCLUSIONS
  Administration of intraoperative continuous hemofiltration is not mandatory in the case of a 3-kg newborn patient with established renal failure needing major cardiosurgery: hemodilution secondary to CPB, transfusion of hemoderivates, and optimal UF rate appear to be effective methods for achieving solute removal. If postoperative continuous hemofiltration is started, however, a "dialytic dose" of 4.5 ml/min allows an adequate creatinine clearance, quick achievement of a steady state of serum creatinine concentration and an eventual acceptable rate of inflammatory mediator removal.
authors.affiliation: Department of Pediatric Cardiosurgery, Bambino Gesù Hospital, Rome, Italy. z.ricci@libero.it
authors.forename: Z
authors.initials: Z
authors.lastname: Ricci
authors.forename: A
authors.initials: A
authors.lastname: Polito
authors.forename: C
authors.initials: C
authors.lastname: Giorni
authors.forename: L
authors.initials: L
authors.lastname: Di Chiara
authors.forename: C
authors.initials: C
authors.lastname: Ronco
authors.forename: S
authors.initials: S
authors.lastname: Picardo
mesh_terms: D002315:Cardiopulmonary Bypass; D006330:Heart Defects, Congenital / Q000150:complications* / Q000601:surgery; D006440:Hemofiltration / Q000379:methods*; D006801:Humans; D007231:Infant, Newborn; D007690:Polycystic Kidney Diseases / Q000151:congenital; D051437:Renal Insufficiency / Q000209:etiology / Q000628:therapy*